Mandate

Vinge Advises Fagerberg & Dellby Fond I AB

May 19, 2008

Ulrika Dellby and Christina Fagerberg was assistance by Vinge in the start-up of a venture capital fund. The fund has raised SEK 320 million. The principal purpose of the fund will be to acquire Swedish companies.

- Ulrika Dellby and Christina Fagerberg have managed to set up a fund when the conditions for doing so have not been opportune, the climate for fundraising has not been particularly favourable, but they have succeeded, says Vinge partner Mattias Schömer, who gave Ulrika Dellby and Christina Fagerberg legal advice.   

In the venture capital industry a buy-out fund acquires developed companies with a stable cash flow. Dellby and Fagerberg will focus on family-owned companies in which the owner wants to remain in the company. Advisors to the fund will, among others, be: Ulf Spendrup, Bo Johnson, Lars Fredriksson and Monica Caneman.

Vinge’s team was made up of Mattias Schömer, Pontus Enquist, Maria Doeser, Joacim Rydergård and Mari Hansson. 
 

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026